Tuesday, March 4, 2014 - 13:53
CMS has released its National Coverage Determination draft memo that proposes Medicare coverage of hepatitis C testing for Medicare beneficiaries at high risk and one time testing of everyone born between 1945 and 1965. The memo was posted today and there is a public comment period through April 3, 2014. NVHR will be pulling together a call soon to discuss public comment strategies and to prepare for implementation/education. Another great victory for us!
Tuesday, February 25, 2014 - 08:09
Read NVHR's letter sent to State Medicaid Directors
Friday, February 14, 2014 - 14:45
Attached a press release from WHO, from last week, which raises liver cancer up to the 2nd leading cause of cancer death worldwide (after lung cancer). It was previously 3rd. This is very compelling evidence to use as we strive to include liver cancer more in our messaging and talks
with our federal/national partners.
Monday, February 3, 2014 - 13:31
Sample letter for medical providers regarding for insurance company denial of treatment using two new FDA approved drugs to treat chronic hepatitis C, Olysio (simeprevir) and Sovaldi (sofosbuvir)
Monday, February 3, 2014 - 13:28
Read NVHR's letter to medical providers regarding the appeals process to appeal insurance company denial of treatment using two new FDA approved drugs to treat chronic hepatitis C, Olysio (simeprevir) and Sovaldi (sofosbuvir)
Friday, January 31, 2014 - 09:38
Friday, January 24, 2014 - 08:23
Tuesday, January 14, 2014 - 13:50
Tuesday, January 14, 2014 - 13:39
Tuesday, January 7, 2014 - 10:32